参考文献/References:
[1] 张耀军,齐婧含. “ 十四五”时期中国人口发展的重大问题[J]. 哈尔滨工业大学学报:社会科学版,2022,24(2):144-153.
[2] Yao SS,Cao GY,Han L,et al. Prevalence and patterns of multimorbidity in a nationally representative sample of older chinese:results from the china health and retirement longitudinal study[J]. J Gerontol A Biol Sci Med Sci,2020,75(10):1974-1980.
[3] Collet JP,Thiele H,Barbato E,et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation[J]. Eur Heart J,2021,42(14):1289-1367.
[4] Fan ZY,Yang Y,Zhang CH,et al. Prevalence and patterns of comorbidity among middle-aged and elderly people in china:a cross-sectional study based on CHARlS data[J]. Int J Gen Med,2021,14:1449-1455.
[5] Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease[J]. J Chronic Dis,1970,23(7):455-468.
[6] Morici N,De Servi S,De Luca L,et al. Management of acute coronary syndromes in older adults[J]. Eur Heart J,2022,43(16):1542-1553.
[7] Steffler M,Li Y,Weir S,et al. Trends in prevalence of chronic disease and multimorbidity in Ontario,Canada[J]. CMAJ,2021,193(8):E270-E277.
[8] Miller PE,Thomas A,Breen TJ,et al. Prevalence of noncardiac multimorbidity in patients admitted to two cardiac intensive care units and their association with mortality[J]. The Am J Med,2021,134(5):653-661.e5.
[9] Hu F,Xu L,Zhou J,et al. Association between overweight,obesity and the prevalence of multimorbidity among the elderly:evidence from a cross-sectional analysis in Shandong,China[J]. Int J Environ Res Public Health,2020,17(22):8355.
[10] 黎艳娜,王艺桥.我国老年人慢性病共病现状及模式研究[J].中国全科医学,2021,24(31):3955-3962,3978.
[11] Zhang F,Wong C,Chiu Y,et al. Prognostic impact of comorbidity measures on outcomes following acute coronary syndrome:A systematic review[J]. Int J Clin Pract,2021,75(10):e14345.
[12] Charlson ME,Pompei P,Ales KL,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation[J]. J Chronic Dis,1987,40(5):373-383.
[13] Charlson ME,Carrozzino D,Guidi J,et al. Charlson comorbidity index: a critical review of clinimetric properties[J]. Psychother Psychosom,2022,91(1):8-35.
[14] Sanchis J,Soler M,Nú?ez J,et al. Comorbidity assessment for mortality risk stratification in elderly patients with acute coronary syndrome[J]. Eur J Intern Med,2019,62:48-53.
[15] Sanchis J,García Acu?a JM, Raposeiras S,et al. Comorbidity burden and revascularization benefit in elderly patients with acute coronary syndrome[J]. Rev Esp Cardiol (Engl Ed),2021,74(9):765-772.
[16] Ofori-Asenso R,Zomer E,Chin KL,et al. Prevalence and impact of non-cardiovascular comorbidities among older adults hospitalized for non-ST segment elevation acute coronary syndrome[J]. Cardiovasc Diagn Ther,2019,9(3):250-261.
[17] Zhang F,Bharadwaj A,Mohamed MO,et al. Impact of charlson co-morbidity index score on management and outcomes after acute coronary syndrome[J]. Am J Cardiol,2020,130:15-23.
[18] Esteve-Pastor MA,Martín E,Alegre O,et al. Impact of frailty and atrial fibrillation in elderly patients with acute coronary syndromes[J]. Eur J Clin Invest,2021,51(5):e13505.
[19] Beska B,Mills GB,Ratcovich H,et al. Impact of multimorbidity on long-term outcomes in older adults with non-ST elevation acute coronary syndrome in the North East of England:a multi-centre cohort study of patients undergoing invasive care[J]. BMJ open,2022,12(7):e061830.
[20] Vicente-Ibarra N,Marín F,Pernías-Escrig V,et al. Impact of anemia as risk factor for major bleeding and mortality in patients with acute coronary syndrome[J]. Eur J Intern Med,2019,61:48-53.
[21] Forman DE,Maurer MS,Boyd C,et al. Multimorbidity in older adults with cardiovascular disease[J]. J Am Coll Cardiol,2018,71(19):2149-2161.
[22] Dillinger JG,Laine M,Bouajila S,et al. Antithrombotic strategies in elderly patients with acute coronary syndrome[J]. Arch Cardiovasc Dis,2021,114(3):232-245.
[23] Godoy LC,Lawler PR,Farkouh ME,et al. Urgent revascularization strategies in patients with diabetes mellitus and acute coronary syndrome[J]. Can J Cardiol,2019,35(8):993-1001.
[24] De Luca G,Verdoia M,Savonitto S,et al. Impact of diabetes on clinical outcome among elderly patients with acute coronary syndrome treated with percutaneous coronary intervention:insights from the ELDERLY ACS 2 trial[J]. J Cardiovasc Med (Hagerstown),2020,21(6):453-459.
[25] Alsayegh F,Alkhamis MA,Ali F,et al. Anemia or other comorbidities?using machine learning to reveal deeper insights into the drivers of acute coronary syndromes in hospital admitted patients[J]. PloS one,2022,17(1):e0262997.
[26] Yan Y,Gong W,Wang X,et al. [Multimorbidity in Elderly Patients with Acute Coronary Syndrome: Insights from BleeMACS registry][J]. Zhonghua Xin Xue Guan Bing Za Zhi,2022,50(5):443-449.
[27] Breen K,Finnegan L,Vuckovic K,et al. Multimorbidity in patients with acute coronary syndrome is associated with greater mortality,higher readmission rates,and increased length of stay:a systematic review[J]. J Cardiovasc Nurs,2020,35(6):E99-E110.
[28] Lemor A,Hernandez GA,Patel N,et al. Predictors and etiologies of 30-day readmissions in patients with non-ST-elevation acute coronary syndrome[J]. Catheter Cardiovasc Interv,2019,93(3):373-379.
[29] Gudnadottir GS,Gudnason T,Wilhelmson K,et al. Multimorbidity and readmissions in older people with acute coronary syndromes[J]. Cardiology,2022,147(2):121-132.
[30] Elbadawi A,Elgendy IY,Ha LD,et al. National trends and outcomes of percutaneous coronary intervention in patients ≥70 years of age with acute coronary syndrome (from the national inpatient sample database)[J]. Am J Cardiol,2019,123(1):25-32.